Science 37 SPAC

Comparable Company Benchmarking. Drug Development Technology Disruptive Healthcare Technology Platforms Vertical Software Revenue CAGR 2021-2023 Enterprise Value / 2023E Revenue 100% 80% 60% 40% 20% 0% 25.0x 20.0x 15.0x 10.0x 5.0x 0.0x 14% CERT 5.8x S37 Source: Company internal data, public filings, and CapitaliQ as of 5/6/21. Science 37 20% SLP 11.7x CERT 26% 14.8x MX CT HCAT SLP mul.…..... 10% 10% TDOC GDRX BFLY BSY GWRE 20% 19.7x MX CT 24% PHR 6.6x 27% 7.4x HCAT TDOC 36% 8.9x 74% PHR 9.7x GDRX 12.8x I BFLY 8.1x TYL 13% TYL 8.4x GWRE 17% DCT 12.3x BSY 20% 25% VEEV NCNO 17.0x 13.3x il DCT 87% S37 17.9x NCNO VEEV

View entire presentation